Lineage Cell Therapeutics, Inc. Operating Income
Lineage Cell Therapeutics, Inc. (LCTX) reported Operating Income of -$8.92 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- Lineage Cell Therapeutics, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$8.92M.
- Lineage Cell Therapeutics, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$7.59M.
- Lineage Cell Therapeutics, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$6.55M.
- Lineage Cell Therapeutics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$3.79M.
- Lineage Cell Therapeutics, Inc. operating income (loss) for fiscal 2025 was -$36.62M.
- Lineage Cell Therapeutics, Inc. operating income (loss) for fiscal 2024 was -$21.48M.
- Lineage Cell Therapeutics, Inc. operating income (loss) for fiscal 2023 was -$24.73M.
- Lineage Cell Therapeutics, Inc. operating income (loss) for fiscal 2022 was -$22.52M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$8.92M 10-Q · filed 2026-08-06 | -$16.52M 10-Q · filed 2026-08-06 | -$23.06M derived: sum of 3 quarters · filed 2026-08-06 | -$26.85M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$7.59M 10-Q · filed 2026-05-12 | -$14.14M derived: sum of 2 quarters · filed 2026-05-12 | -$17.93M derived: sum of 3 quarters · filed 2026-05-12 | -$37.71M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$6.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$10.33M derived: sum of 2 quarters · filed 2026-03-05 | -$30.11M derived: sum of 3 quarters · filed 2026-08-06 | -$36.62M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | -$3.79M 10-Q · filed 2025-11-06 | -$23.57M derived: sum of 2 quarters · filed 2026-08-06 | -$30.07M 10-Q · filed 2025-11-06 | -$35.18M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$19.78M 10-Q · filed 2026-08-06 | -$26.29M 10-Q · filed 2026-08-06 | -$31.39M derived: sum of 3 quarters · filed 2026-08-06 | -$35.23M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$6.50M 10-Q · filed 2026-05-12 | -$11.62M derived: sum of 2 quarters · filed 2026-05-12 | -$15.46M derived: sum of 3 quarters · filed 2026-05-12 | -$21.32M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$5.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$8.95M derived: sum of 2 quarters · filed 2026-03-05 | -$14.82M derived: sum of 3 quarters · filed 2026-03-05 | -$21.48M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | -$3.84M 10-Q · filed 2025-11-06 | -$9.71M derived: sum of 2 quarters · filed 2025-11-06 | -$16.37M 10-Q · filed 2025-11-06 | -$22.73M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$5.87M 10-Q · filed 2025-08-12 | -$12.53M 10-Q · filed 2025-08-12 | -$18.89M derived: sum of 3 quarters · filed 2025-08-12 | -$25.59M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$6.66M 10-Q · filed 2025-05-13 | -$13.02M derived: sum of 2 quarters · filed 2025-05-13 | -$19.73M derived: sum of 3 quarters · filed 2025-05-13 | -$24.75M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$6.36M 10-K · filed 2024-03-07 | -$13.07M derived: sum of 2 quarters · filed 2024-11-14 | -$18.09M derived: sum of 3 quarters · filed 2024-11-14 | -$24.73M 10-K · filed 2025-03-10 | ||||
| 2023-09-30 | -$6.71M 10-Q · filed 2024-11-14 | -$11.73M derived: sum of 2 quarters · filed 2024-11-14 | -$18.37M 10-Q · filed 2024-11-14 | -$25.01M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$5.02M 10-Q · filed 2024-08-08 | -$11.67M 10-Q · filed 2024-08-08 | -$18.30M derived: sum of 3 quarters · filed 2024-08-08 | -$23.56M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$6.64M 10-Q · filed 2024-05-09 | -$13.28M derived: sum of 2 quarters · filed 2024-05-09 | -$18.53M derived: sum of 3 quarters · filed 2024-05-09 | -$22.77M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$6.64M 10-K · filed 2024-03-07 | -$11.89M derived: sum of 2 quarters · filed 2024-03-07 | -$16.12M derived: sum of 3 quarters · filed 2024-03-07 | -$22.52M 10-K · filed 2024-03-07 | ||||
| 2022-09-30 | -$5.25M 10-K · filed 2024-03-07 | -$9.48M derived: sum of 2 quarters · filed 2024-03-07 | -$15.88M 10-Q · filed 2023-11-09 | -$44.12M derived: sum of 4 quarters · filed 2024-03-07 | ||||
| 2022-06-30 | -$4.23M 10-K · filed 2024-03-07 | -$10.63M 10-Q · filed 2023-08-10 | -$38.87M derived: sum of 3 quarters · filed 2024-03-07 | -$45.71M derived: sum of 4 quarters · filed 2024-03-07 | ||||
| 2022-03-31 | -$6.40M 10-K · filed 2024-03-07 | -$34.63M derived: sum of 2 quarters · filed 2024-03-07 | -$41.48M derived: sum of 3 quarters · filed 2024-03-07 | -$48.56M derived: sum of 4 quarters · filed 2024-03-07 | ||||
| 2021-12-31 | -$28.24M 10-K · filed 2023-03-09 | -$35.08M derived: sum of 2 quarters · filed 2023-03-09 | -$42.16M derived: sum of 3 quarters · filed 2023-03-09 | -$49.21M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | -$6.84M 10-K · filed 2023-03-09 | -$13.92M derived: sum of 2 quarters · filed 2023-03-09 | -$20.97M 10-Q · filed 2022-11-10 | -$26.86M derived: sum of 4 quarters · filed 2023-03-09 | ||||
| 2021-06-30 | -$7.08M 10-K · filed 2023-03-09 | -$14.13M 10-Q · filed 2022-08-11 | -$20.01M derived: sum of 3 quarters · filed 2023-03-09 | -$26.74M derived: sum of 4 quarters · filed 2023-03-09 | ||||
| 2021-03-31 | -$7.05M 10-K · filed 2023-03-09 | -$12.93M derived: sum of 2 quarters · filed 2023-03-09 | -$19.66M derived: sum of 3 quarters · filed 2023-03-09 | -$26.06M derived: sum of 4 quarters · filed 2023-03-09 | ||||
| 2020-12-31 | -$5.88M 10-K · filed 2022-03-10 | -$12.61M derived: sum of 2 quarters · filed 2022-03-10 | -$19.01M derived: sum of 3 quarters · filed 2022-03-10 | -$26.45M 10-K · filed 2022-03-10 | ||||
| 2020-09-30 | -$6.72M 10-K · filed 2022-03-10 | -$13.13M derived: sum of 2 quarters · filed 2022-03-10 | -$20.57M 10-Q · filed 2021-11-10 | -$27.44M derived: sum of 4 quarters · filed 2022-03-10 | ||||
| 2020-06-30 | -$6.40M 10-K · filed 2022-03-10 | -$13.84M 10-Q · filed 2021-08-12 | -$20.71M derived: sum of 3 quarters · filed 2022-03-10 | -$29.13M derived: sum of 4 quarters · filed 2022-03-10 | ||||
| 2020-03-31 | -$7.44M 10-K · filed 2022-03-10 | -$14.31M derived: sum of 2 quarters · filed 2022-03-10 | -$22.73M derived: sum of 3 quarters · filed 2022-03-10 | -$33.55M derived: sum of 4 quarters · filed 2022-03-10 | ||||
| 2019-12-31 | -$6.87M 10-K · filed 2021-03-11 | -$15.29M derived: sum of 2 quarters · filed 2021-03-11 | -$26.11M derived: sum of 3 quarters · filed 2021-03-11 | -$38.88M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | -$8.42M 10-K · filed 2021-03-11 | -$19.24M derived: sum of 2 quarters · filed 2021-03-11 | -$32.00M 10-Q · filed 2020-11-04 | -$42.11M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-06-30 | -$10.82M 10-K · filed 2021-03-11 | -$23.58M 10-Q · filed 2020-08-06 | -$33.69M derived: sum of 3 quarters · filed 2021-03-11 | -$44.05M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-03-31 | -$12.76M 10-K · filed 2021-03-11 | -$22.87M derived: sum of 2 quarters · filed 2021-03-11 | -$33.23M derived: sum of 3 quarters · filed 2021-03-11 | -$42.37M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2018-12-31 | -$10.11M 10-K · filed 2020-03-12 | -$20.46M derived: sum of 2 quarters · filed 2020-03-12 | -$29.61M derived: sum of 3 quarters · filed 2020-03-12 | -$41.80M 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | -$10.36M 10-K · filed 2020-03-12 | -$19.50M derived: sum of 2 quarters · filed 2020-03-12 | -$31.58M 10-Q · filed 2019-11-12 | -$41.25M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | -$9.14M 10-K · filed 2020-03-12 | -$21.22M 10-Q · filed 2019-08-08 | -$30.89M derived: sum of 3 quarters · filed 2020-03-12 | -$40.41M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | -$12.19M 10-K · filed 2020-03-12 | -$21.75M derived: sum of 2 quarters · filed 2020-03-12 | -$31.26M derived: sum of 3 quarters · filed 2020-03-12 | -$39.83M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | -$9.56M 10-K · filed 2019-03-14 | -$19.08M derived: sum of 2 quarters · filed 2019-03-14 | -$27.64M derived: sum of 3 quarters · filed 2019-03-14 | -$38.90M 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | -$9.51M 10-K · filed 2019-03-14 | -$18.08M derived: sum of 2 quarters · filed 2019-03-14 | -$29.34M 10-Q · filed 2018-11-08 | -$40.59M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2017-06-30 | -$8.56M 10-K · filed 2019-03-14 | -$10.32M 10-Q · filed 2017-08-09 | -$19.83M 10-Q · filed 2018-08-02 | -$21.58M 10-Q · filed 2017-08-09 | -$31.08M derived: sum of 3 quarters · filed 2019-03-14 | -$40.63M derived: sum of 4 quarters · filed 2019-03-14 | ||
| 2017-03-31 | -$11.26M 10-K · filed 2019-03-14 | -$22.52M derived: sum of 2 quarters · filed 2019-03-14 | -$32.07M derived: sum of 3 quarters · filed 2019-03-14 | -$46.47M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2016-12-31 | -$11.25M 10-K · filed 2018-03-15 | -$20.81M derived: sum of 2 quarters · filed 2018-03-15 | -$35.21M derived: sum of 3 quarters · filed 2018-03-15 | -$58.97M 10-K · filed 2018-03-15 | ||||
| 2016-09-30 | -$9.55M 10-K · filed 2018-03-15 | -$23.96M derived: sum of 2 quarters · filed 2018-03-15 | -$47.71M 10-Q · filed 2017-11-09 | -$69.42M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-06-30 | -$14.40M 10-K · filed 2018-03-15 | -$38.16M 10-Q · filed 2017-08-09 | -$59.87M derived: sum of 3 quarters · filed 2018-03-15 | -$76.97M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-03-31 | -$23.76M 10-K · filed 2018-03-15 | -$45.47M derived: sum of 2 quarters · filed 2018-03-15 | -$62.57M derived: sum of 3 quarters · filed 2018-03-15 | -$76.06M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-12-31 | -$21.71M 10-K · filed 2017-03-16 | -$21.70M 10-K · filed 2016-03-15 | -$38.81M derived: sum of 2 quarters · filed 2017-03-16 | -$52.31M derived: sum of 3 quarters · filed 2017-03-16 | -$65.81M 10-K · filed 2018-03-15 | |||
| 2015-09-30 | -$17.10M 10-K · filed 2017-03-16 | -$30.60M derived: sum of 2 quarters · filed 2017-03-16 | -$44.11M 10-Q · filed 2016-11-04 | -$58.51M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | -$13.50M 10-K · filed 2017-03-16 | -$27.00M 10-Q · filed 2016-08-09 | -$41.40M derived: sum of 3 quarters · filed 2017-03-16 | -$53.54M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | -$13.50M 10-K · filed 2017-03-16 | -$13.50M 10-Q · filed 2015-05-08 | -$27.91M derived: sum of 2 quarters · filed 2017-03-16 | -$40.05M derived: sum of 3 quarters · filed 2017-03-16 | -$53.11M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | -$14.40M 10-K · filed 2016-03-15 | -$14.40M 10-K · filed 2015-03-11 | -$26.54M derived: sum of 2 quarters · filed 2016-03-15 | -$39.60M derived: sum of 3 quarters · filed 2016-03-15 | -$50.68M 10-K · filed 2017-03-16 | -$50.68M 10-K · filed 2015-03-11 | ||
| 2014-09-30 | -$12.14M 10-K · filed 2016-03-15 | -$12.14M 10-Q · filed 2014-11-07 | -$25.20M derived: sum of 2 quarters · filed 2016-03-15 | -$36.28M 10-Q · filed 2015-11-09 | -$36.28M 10-Q · filed 2014-11-07 | -$65.63M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-06-30 | -$13.06M 10-K · filed 2016-03-15 | -$13.06M 10-Q · filed 2014-08-11 | -$24.18M 10-Q · filed 2015-08-10 | -$24.18M 10-Q · filed 2014-08-11 | -$53.49M derived: sum of 3 quarters · filed 2016-03-15 | -$63.70M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-03-31 | -$11.14M 10-K · filed 2016-03-15 | -$11.14M 10-Q · filed 2014-05-12 | -$40.43M derived: sum of 2 quarters · filed 2016-03-15 | -$50.63M derived: sum of 3 quarters · filed 2016-03-15 | -$58.75M derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2013-12-31 | -$29.29M 10-K · filed 2015-03-11 | -$39.50M derived: sum of 2 quarters · filed 2015-03-11 | -$47.61M derived: sum of 3 quarters · filed 2015-03-11 | -$55.99M 10-K · filed 2016-03-15 | -$55.99M 10-K · filed 2014-03-17 | |||
| 2013-09-30 | -$10.20M 10-K · filed 2015-03-11 | -$18.32M derived: sum of 2 quarters · filed 2015-03-11 | -$26.69M 10-Q · filed 2014-11-07 | -$33.76M derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-06-30 | -$8.12M 10-K · filed 2015-03-11 | -$16.52M 10-Q · filed 2014-08-11 | -$23.56M derived: sum of 3 quarters · filed 2015-03-11 | -$29.50M derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-03-31 | -$8.38M 10-K · filed 2015-03-11 | -$15.44M derived: sum of 2 quarters · filed 2015-03-11 | -$21.39M derived: sum of 3 quarters · filed 2015-03-11 | -$27.47M derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2012-12-31 | -$7.06M 10-K · filed 2014-03-17 | -$13.01M derived: sum of 2 quarters · filed 2014-03-17 | -$19.09M derived: sum of 3 quarters · filed 2014-03-17 | -$25.00M 10-K · filed 2015-03-11 | ||||
| 2012-09-30 | -$5.95M 10-K · filed 2014-03-17 | -$12.03M derived: sum of 2 quarters · filed 2014-03-17 | -$17.94M 10-Q · filed 2013-11-12 | -$23.39M derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-06-30 | -$6.08M 10-K · filed 2014-03-17 | -$11.99M 10-Q · filed 2013-08-09 | -$17.44M derived: sum of 3 quarters · filed 2014-03-17 | -$21.67M derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-03-31 | -$5.92M 10-K · filed 2014-03-17 | -$11.36M derived: sum of 2 quarters · filed 2014-03-17 | -$15.60M derived: sum of 3 quarters · filed 2014-03-17 | -$20.58M derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2011-12-31 | -$5.45M 10-K · filed 2013-03-18 | -$9.68M derived: sum of 2 quarters · filed 2013-03-18 | -$14.66M derived: sum of 3 quarters · filed 2013-03-18 | -$18.69M 10-K · filed 2014-03-17 | ||||
| 2011-09-30 | -$4.23M 10-K · filed 2013-03-18 | -$9.21M derived: sum of 2 quarters · filed 2013-03-18 | -$13.23M 10-Q · filed 2012-11-09 | -$17.00M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | -$4.98M 10-K · filed 2013-03-18 | -$9.01M 10-Q · filed 2012-08-09 | -$12.76M derived: sum of 3 quarters · filed 2013-03-18 | -$15.22M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-03-31 | -$4.03M 10-K · filed 2013-03-18 | -$4.03M 10-Q · filed 2012-05-10 | -$7.78M derived: sum of 2 quarters · filed 2013-03-18 | -$10.24M derived: sum of 3 quarters · filed 2013-03-18 | -$12.56M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2010-12-31 | -$3.76M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$6.21M derived: sum of 2 quarters · filed 2013-03-18 | -$8.53M derived: sum of 3 quarters · filed 2013-03-18 | -$9.85M 10-K · filed 2013-03-18 | ||||
| 2010-09-30 | -$2.46M 10-Q · filed 2011-11-08 | -$4.77M derived: sum of 2 quarters · filed 2011-11-08 | -$6.10M 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | -$2.32M 10-Q · filed 2011-08-09 | -$3.64M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | -$3.52M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |